BioSpace News Archive

Growth capital to support expansion of Suvoda’s clinical trial software and services

Technavio has announced its latest market research report titled global esophageal cancer drugs market 2019-2023

Making the M-60 the Most Versatile Extraction Press in the Industry

So-Young International Inc., the most popular online destination for discovering, evaluating and reserving medical aesthetic services in China, announced its unaudited financial results for the third quarter ended September 30, 2019.

For twenty-five years, Invivoscribe has improved the quality of healthcare worldwide by providing high quality, standardized reagents, tests, and bioinformatics tools to advance the field of precision medicine.

New FDA Approval Extends Label to Including the i:X’s Detection of Bacteria and Digital Wound Measurement

AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the companies have received marketing authorization from China’s National Medical Products Administration (NMPA) for LYNPARZA

Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced the appointment of biopharmaceutical industry veteran Juan Andres to its Board of Directors.

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a CE Mark from DEKRA Certification B.V. and Therapeutic Goods Administration (TGA) clearance in Australia to market NeoGraft 2.0 for hair restoration.

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the initiation of a Phase 2 clinical study of its novel NMDA receptor modulator, NYX-458, for the treatment of mild cognitive impairment associated with Parkinson’s disease.